Akwetey Samuel A, Osman Abdul-Halim, Kotey Fleischer C N, Awere-Duodu Aaron, Odoom Alex, Opoku-Asare Bismark, Donkor Eric S
Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana.
Department of Clinical Microbiology, University for Development Studies, Tamale, Ghana.
BMC Public Health. 2025 Aug 6;25(1):2671. doi: 10.1186/s12889-025-22476-y.
Meningitis is a significant health concern that is associated with high fatality rates, particularly in resource-limited settings such as Ghana, whose northern regions lie within the African Meningitis Belt. Despite the plethora of primary research data on meningitis in Ghana, a systematic review that provides comprehensive information to guide prevention, control, and management efforts is yet to be undertaken. This systematic review, therefore, aimed at bridging this gap by describing the epidemiology of meningitis in Ghana, including its prevalence, aetiology, and antimicrobial resistance.
A comprehensive review of electronic databases, including PubMed and Scopus, was conducted between 2nd and 4th December, 2023, following the established PRISMA guidelines. The search encompassed articles published from 1975 to 2023. With no age limitations on study participants, data extraction was performed on peer-reviewed journal articles reporting primary findings. Studies that exclusively reported on meningitis in animal models, in vitro or in vivo were excluded. Studies with a sample size of less than ten were excluded from the analysis. A meta-analysis was carried out to determine the pooled estimate of meningitis prevalence in the country.
There were 71,205 suspected meningitis cases analysed during the study period, with 3865 confirmed, and a pooled (overall) prevalence of 18.13%. Specifically, the cases that occurred during non-outbreak and outbreak periods had a pooled prevalence of 16.22% and 23.91%, respectively. The case fatality rates ranged from 20% to 47% between 1998 and 2015 and from 0.82% to 28.6% between 2016 and 2021. The three northern regions - Upper East (30.8%-54.35%), Northern (16.3%-46.4%), and Upper West (17.96%-38.8%) - had relatively high meningitis prevalence, while the Greater Accra and Ashanti Regions had prevalence ranging between 0.8% and 3.29%. Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae were the predominant isolates, accounting for 0.48%-77.7%, 2.5%-69.5%, and 0.90%-3.40% of the cases, respectively. All bacterial isolates from meningitis cases were susceptible to ceftriaxone. The most common Neisseria meningitidis serogroups were W135, A, Y, and X, while Serotype 1 dominated among the Streptococcus pneumoniae serotypes.
There is a disparity in the distribution of meningitis in Ghana, with the highest prevalence occurring in the northern parts of the country. There seems to have been a reduction in the case fatality rate over the years, probably due to interventions such as vaccinations. Ceftriaxone continues to be a suitable treatment option for meningitis. There should be continuous surveillance of meningitis aetiological agents - especially serotyping of the common pathogens - to help guide national vaccination policies and programmes.
脑膜炎是一个重大的健康问题,死亡率很高,尤其是在资源有限的地区,如加纳,其北部地区位于非洲脑膜炎带内。尽管加纳有大量关于脑膜炎的原始研究数据,但尚未进行系统综述以提供全面信息来指导预防、控制和管理工作。因此,本系统综述旨在通过描述加纳脑膜炎的流行病学情况,包括其患病率、病因和抗菌药物耐药性,来填补这一空白。
2023年12月2日至4日,按照既定的PRISMA指南,对包括PubMed和Scopus在内的电子数据库进行了全面检索。检索范围涵盖1975年至2023年发表的文章。研究参与者无年龄限制,对报告主要研究结果的同行评议期刊文章进行数据提取。专门报告动物模型、体外或体内脑膜炎情况的研究被排除。样本量少于10的研究被排除在分析之外。进行荟萃分析以确定该国脑膜炎患病率的合并估计值。
在研究期间共分析了71205例疑似脑膜炎病例,其中3865例确诊,合并(总体)患病率为18.13%。具体而言,非暴发期和暴发期发生的病例合并患病率分别为16.22%和23.91%。1998年至2015年期间病死率在20%至47%之间,2016年至2021年期间在0.82%至28.6%之间。北部三个地区——上东部(30.8% - 54.35%)、北部(16.3% - 46.4%)和上西部(17.96% - 38.8%)——脑膜炎患病率相对较高,而大阿克拉和阿散蒂地区的患病率在0.8%至3.29%之间。肺炎链球菌、脑膜炎奈瑟菌和流感嗜血杆菌是主要分离菌株,分别占病例的0.48% - 77.7%、2.5% - 69.5%和0.90% - 3.40%。脑膜炎病例的所有细菌分离株对头孢曲松均敏感。最常见的脑膜炎奈瑟菌血清群是W135、A、Y和X,而肺炎链球菌血清型中1型占主导。
加纳脑膜炎的分布存在差异,该国北部患病率最高。多年来病死率似乎有所下降,可能是由于疫苗接种等干预措施。头孢曲松仍然是治疗脑膜炎的合适选择。应持续监测脑膜炎病原体——尤其是常见病原体的血清分型——以帮助指导国家疫苗接种政策和计划。